DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
GnRH signaling pathway	R-HSA-168638	map04912	Prestwick-920	None	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	octopamine	73277	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	octopamine	73277	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	octopamine	73277	drug-path
Olfactory transduction	R-HSA-9751605	map04740	octopamine	73277	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	octopamine	73277	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	octopamine	73277	drug-path
Asthma	R-HSA-444620	map05310	octopamine	73277	drug-path
Allograft rejection	R-HSA-9679028	map05330	octopamine	73277	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	octopamine	73277	drug-path
Glioma	Q9NZM4	map05214	octopamine	73277	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	octopamine	73277	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	octopamine	73277	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	ceftazidime	5280953	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	ceftazidime	5280953	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ceftazidime	5280953	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	ceftazidime	5280953	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	ceftazidime	5280953	drug-path
Adherens junction	R-HSA-451386	map04520	ceftazidime	5280953	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	ceftazidime	5280953	drug-path